Canntab Therapeutics Ltd. said Sheldon Inwentash resigned from its board to pursue other opportunities.
The Canada-based company develops advanced pharmaceutical-grade formulations of cannabinoids.
Canntab Therapeutics director resigns
COVID-19 Pandemic Likely To Cause US Telemedicine Boom
Gauging Supply Chain Risk In Volatile Times
Cannabis: Hashing Out a Budding Industry
IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help
Canntab Therapeutics director resigns
- Author Vince Iral
- Theme Healthcare & Pharmaceuticals
- Author
- Vince Iral
- Theme
- Healthcare & Pharmaceuticals